AFAA is proud to celebrate the achievements of AFAA Board Member Diana Zhang, founder of Preview Health, who has announced the launch of a groundbreaking brain health blood test trial.

Motivated by the need for earlier detection and intervention in brain disease, Diana made the decision to pursue an entrepreneurial and research-driven path following the completion of a PhD. The result is Preview Health, a company focused on unlocking precision brain healthcare through innovative diagnostic tools.

After more than two years of intensive research and development, alongside extensive consultation with patients and the broader community, Preview Health is now inviting the first 500 participants to trial its new brain health blood test. The test aims to identify signs of metabolic dysfunction that may impact brain function, providing individuals with valuable insights into their brain health and the opportunity to monitor changes over time.

With brain diseases often detected years after symptoms first begin and many cases considered preventable, innovations such as this have the potential to transform how individuals understand and manage their health.

AFAA congratulates Diana on this significant milestone and looks forward to following the continued impact of this important work.

To learn more or join the waitlist, visit: www.preview.health